Roche said it has removed its thrombolytic drug tenecteplase from phase 3 for for acute ischaemic stroke, along with several earlier-stage projects. The fibrin-specific plasminogen activator – which ...

Against all the odds, Roche's Genentech unit has won FDA approval for its clot-busting drug TNKase as a treatment for acute ischaemic stroke, after all but abandoning the project a couple of years ago ...

People typically focus on the content of advice, but they should pay equal attention to the process. by David A. Garvin and Joshua D. Margolis Seeking and giving advice are central to effective ...

Since the inception of TOMS Shoes in 2006, the buy-one give-one business model has been widely embraced (and criticized) by consumers and businesses alike as an effective model for creating both ...

shape tomorrow’s leaders today. Kim Conti DeGroot BS '90 and Daniel DeGroot Kim Conti DeGroot BS ’90 and her husband, Daniel DeGroot, understand what it means to invest in their communities—both near ...

Investopedia contributors come from a range of backgrounds, and over 25 years there have been thousands of expert writers and editors who have contributed. Lea Uradu, J.D., is a Maryland state ...